Low dose of glucocorticoid decreases the incidence of complications in severely burned patients by attenuating systemic inflammation

Journal of Critical Care

Volumn 30, Issue 2, 2015, Pages 436.e7-436.e11

  Huang, Guofeng ^a   Liang, Bowei ^a   Liu, Guojun ^a   Liu, Kuisheng ^a   Ding, Zhenqi ^a  

^a Orthopaedic Center of People s Liberation Army   (China)

Author keywords

Complication; Cytokine; Low dose of glucocorticoid; Severe burn; Systemic inflammatory response

Indexed keywords

C REACTIVE PROTEIN; HYDROCORTISONE; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; CYTOKINE; GLUCOCORTICOID;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; BURN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INCIDENCE; LENGTH OF STAY; LOW DRUG DOSE; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROTEIN BLOOD LEVEL; SEPSIS; STRESS ULCER; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; BURNS; IMMUNOLOGY; INFLAMMATION; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STOMACH ULCER; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS; BURNS; C-REACTIVE PROTEIN; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; LENGTH OF STAY; MALE; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDIES; SEPSIS; STOMACH ULCER; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84923068819     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.09.016     Document Type: Article

References (41)

1. Wolf S.E., Arnoldo B.D. The year in burns 2012. Burns 2013, 39(8):1501-1513.
2. Merritt E.K., Cross J.M., Bamman M.M. Inflammatory and protein metabolism signaling responses in human skeletal muscle after burn injury. J Burn Care Res 2012, 33(2):291-297.
3. Atiyeh B.S., Gunn S.W., Dibo S.A. Metabolic implications of severe burn injuries and their management: a systematic review of the literature. World J Surg 2008, 32(8):1857-1869.
4. Yang Q., Berthiaume F., Androulakis I.P. A quantitative model of thermal injury-induced acute inflammation. Math Biosci 2011, 229(2):135-148.
5. Finnerty C.C., Herndon D.N., Przkora R., Pereira C.T., Oliveira H.M., Queiroz D.M., et al. Cytokine expression profile over time in severely burned pediatric patients. Shock 2006, 26(1):13-19.
6. Stanojcic M., Chen P., Harrison R.A., Wang V., Antonyshyn J., Zúñiga-Pflücker J.C., et al. Leukocyte infiltration and activation of the NLRP3 inflammasome in white adipose tissue following thermal injury. Crit Care Med 2014, 42(6):1357-1364.
7. Gragnani A., Cezillo M.V., da Silva I.D., de Noronha S.M., Correa-Noronha S.A., Ferreira L.M. Gene expression profile of cytokines and receptors of inflammation from cultured keratinocytes of burned patients. Burns 2014, 40(5):947-956.
8. de Bandt J.P., Chollet-Martin S., Hernvann A., Lioret N., du Roure L.D., Lim S.K., et al. Cytokine response to burn injury: relationship with protein metabolism. J Trauma 1994, 36(5):624-628.
9. Giannoudis P.V., Harwood P.J., Loughenbury P., Van Griensven M., Krettek C., Pape H.C. Correlation between IL-6 levels and the systemic inflammatory response score: can an IL-6 cutoff predict a SIRS state?. J Trauma 2008, 65(3):646-652.
10. Maier B., Lefering R., Lehnert M., Laurer H.L., Steudel W.I., Neugebauer E.A., et al. Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma. Shock 2007, 28(6):668-674.
11. Park M.S., Salinas J., Wade C.E., Wang J., Martini W., Pusateri A.E., et al. Combining early coagulation and inflammatory status improves prediction of mortality in burned and nonburned trauma patients. J Trauma 2008, 64(2 Suppl.):S188-S194.
12. Foldi V., Lantos J., Bogar L., Roth E., Weber G., Csontos C. Effects of fluid resuscitation methods on the pro- and anti-inflammatory cytokines and expression of adhesion molecules after burn injury. J Burn Care Res 2010, 31(3):480-491.
13. Jeschke M.G., Finnerty C.C., Kulp G.A., Przkora R., Mlcak R.P., Herndon D.N. Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children. Pediatr Crit Care Med 2008, 9(2):209-216.
14. Costantini T.W., Peterson C.Y., Kroll L., Loomis W.H., Putnam J.G., Wolf P., et al. Burns, inflammation, and intestinal injury: protective effects of an anti-inflammatory resuscitation strategy. J Trauma 2009, 67(6):1162-1168.
15. Csontos C., Rezman B., Foldi V., Bogar L., Drenkovics L., Röth E., et al. Effect of N-acetylcysteine treatment on oxidative stress and inflammation after severe burn. Burns 2012, 38(3):428-437.
16. Fang Y., Xu P., Gu C., Wang Y., Fu X.J., Yu W.R., et al. Ulinastatin improves pulmonary function in severe burn-induced acute lung injury by attenuating inflammatory response. J Trauma 2011, 71(5):1297-1304.
17. Meduri G.U., Annane D., Chrousos G.P., Marik P.E., Sinclair S.E. Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest 2009, 136(6):1631-1643.
18. Hardy R., Raza K., Cooper M. Endogenous glucocorticoids in inflammation: contributions of systemic and local responses. Swiss Med Wkly 2012, 142:w13650.
19. Rhen T., Cidlowski J.A. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 2005, 353(16):1711-1723.
20. Arabi Y.M., Aljumah A., Dabbagh O., Tamim H.M., Rishu A.H., Al-Abdulkareem A., et al. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. CMAJ 2010, 182(18):1971-1977.
21. Annane D., Sébille V., Charpentier C., Bollaert P.E., François B., Korach J.M., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288(7):862-871.
22. Brown D.L., Archer S.B., Greenhalgh D.G., Washam M.A., James L.E., Warden G.D. Inhalation injury severity scoring system: a quantitative method. J Burn Care Rehabil 1996, 17(6 Pt. 1):552-557.
23. Jaroszewski D.E., Webb B.J., Leslie K.O. Diagnosis and management of lung infections. Thorac Surg Clin 2012, 22(3):301-324.
24. Pitimana-aree S., Forrest D., Brown G., Anis A., Wang X.H., Dodek P. Implementation of a clinical practice guideline for stress ulcer prophylaxis increases appropriateness and decreases cost of care. Intensive Care Med 1998, 24(3):217-223.
25. Barrio V. Usefulness and need for standardized criteria in diagnosing acute renal failure in critical patients. Med Intensiva 2012, 36(4):247-249.
26. Dellinger R.P., Levy M.M., Carlet J.M., Bion J., Parker M.M., Jaeschke R., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2008, 36(1):296-327.
27. Briegel J., Forst H., Haller M., Schelling G., Kilger E., Kuprat G., et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999, 27(4):723-732.
28. Jaeschke R., Guyatt G. Steroid use in critically ill septic patients: acknowledging the uncertainty. Pol Arch Med Wewn 2009, 119(11):694-696.
29. Jones W.G., Minei J.P., Richardson R.P., Fahey T.J., Calvano S.E., Antonacci A.C., et al. Pathophysiologic glucocorticoid elevations promote bacterial translocation after thermal injury. Infect Immun 1990, 58(10):3257-3261.
30. Fand R. Treatment of mild and severe burns with topical, oral, IM, and IV cortisone. Conn Med 2008, 72(7):441.
31. Hossain D.D. Steroid in the management of 2° superficial burn: a report. Burns 2011, 37(8):1460-1461.
32. Hawes A.S., Richardson R.P., Antonacci A.C., Calvano S.E. Chronic pathophysiologic elevation of corticosterone after thermal injury or thermal injury and burn wound infection adversely affects body mass, lymphocyte numbers, and outcome. J Burn Care Rehabil 1995, 16(1):1-15.
33. Jeschke M.G., Norbury W.B., Finnerty C.C., Branski L.K., Herndon D.N. Propranolol does not increase inflammation, sepsis, or infectious episodes in severely burned children. J Trauma 2007, 62(3):676-681.
34. Mace J.E., Park M.S., Mora A.G., Chung K.K., Martini W., White C.E., et al. Differential expression of the immunoinflammatory response in trauma patients: burn vs. non-burn. Burns 2012, 38(4):599-606.
35. Tschaikowsky K., Hedwig-Geissing M., Braun G.G., Radespiel-Troeger M. Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis. J Crit Care 2011, 26(1):54-64.
36. Dehne M.G., Sablotzki A., Hoffmann A., Mühling J., Dietrich F.E., Hempelmann G. Alterations of acute phase reaction and cytokine production in patients following severe burn injury. Burns 2002, 28(6):535-542.
37. Barber R.C., Aragaki C.C., Rivera-Chavez F.A., Purdue G.F., Hunt J.L., Horton J.W. TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet 2004, 41(11):808-813.
38. del Aguila L.F., Claffey K.P., Kirwan J.P. TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. Am J Physiol 1999, 276(5 Pt. 1):E849-E855.
39. Kim H.S., Kim J.H., Yim H., Kim D. Changes in the levels of interleukins 6, 8, and 10, tumor necrosis factor alpha, and granulocyte-colony stimulating factor in Korean burn patients: relation to burn size and postburn time. Ann Lab Med 2012, 32(5):339-344.
40. Lyons A., Goebel A., Mannick J.A., Lederer J.A. Protective effects of early interleukin 10 antagonism on injury-induced immune dysfunction. Arch Surg 1999, 134(12):1317-1323.
41. Lederer J.A., Rodrick M.L., Mannick J.A. The effects of injury on the adaptive immune response. Shock 1999, 11(3):153-159.